Delivery Order SPE2DB22D2211-SPE2DB24FNET4
Award Date 4/12/24
Potential Completion Date 4/15/24
Potential Value $5.2K
Federal Agency
Ultimate Awardee
PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The U.S. Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation, to provide OZEMPIC 0.25-0.5 MG/DOSE PEN 3ML pharmaceutical products. The contract, valued at $3,071.16, has a period of performance through March 29, 2024 and was not set-aside. AmerisourceBergen Drug Corp holds an indefinite delivery contract with DLA valued at up to $999,999,999.00 through December 31, 2025, which serves as...
- The Defense Logistics Agency (DLA) has awarded a $5,431.64 firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, for the supply of OZEMPIC 1 MG/DOSE (4 MG/3 ML) 3ML pharmaceutical products. This delivery order is part of a larger indefinite delivery contract (IDC) with a potential value of $999,999,999.00 and a performance period through December 31, 2025, which serves as Amerisourcebergen's primary contract vehicle for delivering...
- The Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to provide OZEMPIC 2 MG/DOSE (8 MG/3 ML) 3ML medication. The contract, valued at $1,161.08, has a completion date of January 31, 2024. Amerisourcebergen Drug Corp is the prime contractor on this delivery order, which falls under a larger indefinite delivery contract (IDC) awarded by DLA with a potential value of $999,999,999.00 and a...
- The U.S. Defense Logistics Agency (DLA) has awarded a firm fixed price delivery order contract to the prime contractor, Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation. The contract, with a potential value of $1,741.62, is for the delivery of the pharmaceutical product OZEMPIC 1 MG/DOSE (4 MG/3 ML) 3ML. This delivery order is part of a larger indefinite delivery contract (IDC) awarded by DLA to Amerisourcebergen Drug Corp, with a potential value of $999,999,999.00...
- The U.S. Defense Logistics Agency (DLA) has awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to provide the pharmaceutical product OZEMPIC 1 MG/DOSE (4 MG/3 ML) 3ML. The contract has a completion date of February 13, 2024 and a potential value of $1,129.08. This delivery order is issued under a larger indefinite delivery contract (IDC) between DLA and Amerisourcebergen Drug Corp, with a maximum ordering value of...
- The U.S. Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, for the supply of OZEMPIC 1 MG/DOSE (4 MG/3 ML) 3ML pharmaceutical product. The contract has a completion date of April 15, 2024 and a ceiling value of $4,137.57. This delivery order is issued under an indefinite delivery contract (IDC) with a potential value of $999,999,999.00 and a performance period through December 31, 2025,...
- The U.S. Defense Logistics Agency (DLA) awarded a firm fixed price delivery order to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation, for the supply of Ozempic 1 mg/dose (4 mg/3 ml) 3 ml medication. The order, valued at $15,285.04, has an ultimate completion date of April 9, 2024. AmerisourceBergen Drug Corp is the prime contractor on an indefinite delivery contract (IDC) with DLA, valued up to $999,999,999.00 through December 31, 2025, which serves as the primary...
- The U.S. Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation, to provide Ozempic 1 mg/dose (4 mg/3 ml) 3 ml medication. The award, valued at $11,922.74, has an ultimate completion date of April 12, 2024. AmerisourceBergen Drug Corp holds an indefinite delivery contract with DLA, valued at up to $999,999,999.00 through December 31, 2025, which serves as the primary vehicle for the company...
- The Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to provide OZEMPIC 1 MG/DOSE (4 MG/3 ML) 3ML medication. The contract has a potential value of $7,475.24 and a performance period through February 16, 2024. Amerisourcebergen Drug Corp is the prime contractor and no set-aside designations were used. This delivery order contract is issued under a larger indefinite delivery contract...
- The U.S. Defense Logistics Agency (DLA) awarded a firm fixed-price delivery order to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation, for the supply of OZEMPIC 0.25-0.5 MG/DOSE PEN 3ML. The $1,451.30 award has an ultimate completion date of April 8, 2024. This delivery order is part of a larger $999,999,999.00 indefinite delivery contract (IDC) awarded by DLA to AmerisourceBergen Drug Corp as the sole contractor. The IDC serves as the primary vehicle for...